We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...

The rising cost of prescription medications in the U.S. is a serious issue, particularly for those needing life-saving ...

After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer ...

Vyloy is the first CLDN18.2-targeted treatment to reach the US market alongside Roche's Ventana CLDN18 RxDx Assay for identifying eligible patients.

Drug shortages were estimated to be at a record high in 2023, with 309 reported according to US pharmacists - which was also ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

The family eventually found that medication. Later, two others Abby needed were hard to find. The Brays, like thousands of ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Akero Therapeutics (NASDAQ:AKRO) is a biotechnology company that is developing a treatment for Metabolic ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) is a clinical-stage biopharmaceutical company specializing in developing therapies for ...

Ahead of the November general election, the Southern California News Group compiled a list of questions to pose to the ...